Evogene (NASDAQ:EVGN) just reported results for the second quarter of 2024.
- Evogene reported earnings per share of -$1.06. This was below the analyst estimate for EPS of -12 cents.
- The company reported revenue of $914,000.
- This was 14.25% better than the analyst estimate for revenue of $800,000.